一个阿托瓦斯塔丁诱导的阳性抗HMGCR免疫媒介性死肌病病例
Nattanicha Chaisrimaneepan1, Jerapas Thongpiya1, Pitchaporn Yingchoncharoen1
1Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA.
Clinical case reports
|March 4, 2024
概括
药物可以导致肌肉问题 (肌肉病变). 如果在停止服用药物后仍然存在软弱,请考虑免疫介导肌肉病作为潜在的原因.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 类药物是被广泛处方的降胆固醇药物.
- 达丁类药物诱导的肌肉病是已知的不良影响之一.
- 大多数病例在戒毒后就会消失.
研究的目的:
- 要强调考虑免疫介导肌肉病变的重要性.
- 为了区分免疫介导肌肉病与典型的他类药物诱导肌肉病.
主要方法:
- 临床病例审查.
- 肌肉病的差异诊断. 肌肉病的差异诊断. 肌肉病的差异诊断. 肌肉病的差异诊断.
主要成果:
- 停止他类药物治疗可以解决典型的肌肉病变.
- 尽管停止使用他类药物,但肌肉疲软持续或恶化需要进一步评估.
结论:
- 免疫媒介性肌肉病是使用他类药物后持续肌肉衰弱的潜在原因.
- 早期识别和诊断免疫介导肌肉病是适当管理的关键.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831